Bhardwaj N, Young J W, Nisanian A J, Baggers J, Steinman R M
Laboratory of Cellular Physiology and Immunology, Rockefeller University, New York, New York.
J Exp Med. 1993 Aug 1;178(2):633-42. doi: 10.1084/jem.178.2.633.
Dendritic cells are potent antigen-presenting cells for several primary immune responses and therefore provide an opportunity for evaluating the amounts of cell-associated antigens that are required for inducing T cell-mediated immunity. Because dendritic cells express very high levels of major histocompatibility complex (MHC) class II products, it has been assumed that high levels of ligands bound to MHC products ("signal one") are needed to stimulate quiescent T cells. Here we describe quantitative aspects underlying the stimulation of human blood T cells by a bacterial superantigen, staphylococcal enterotoxin A (SEA). The advantages of superantigens for quantitative studies of signal one are that these ligands: (a) engage MHC class II and the T cell receptor but do not require processing; (b) are efficiently presented to large numbers of quiescent T cells; and (c) can be pulsed onto dendritic cells before their application to T cells. Thus one can relate amounts of dendritic cell-associated SEA to subsequent lymphocyte stimulation. Using radioiodinated SEA, we noted that dendritic cells can bind 30-200 times more superantigen than B cells and monocytes. Nevertheless, this high SEA binding does not underlie the strong potency of dendritic cells to present antigen to T cells. Dendritic cells can sensitize quiescent T cells, isolated using monoclonals to appropriate CD45R epitopes, after a pulse of SEA that occupies a maximum of 0.1% of surface MHC class II molecules. This corresponds to an average of 2,000 molecules per dendritic cell. At these low doses of bound SEA, monoclonal antibodies to CD3, CD4, and CD28 almost completely block T cell proliferation. In addition to suggesting new roles for MHC class II on dendritic cells, especially the capture and retention of ligands at low external concentrations, the data reveal that primary T cells can generate a response to exceptionally low levels of signal one as long as these are delivered on dendritic cells.
树突状细胞是几种主要免疫反应中强大的抗原呈递细胞,因此为评估诱导T细胞介导的免疫所需的细胞相关抗原量提供了一个机会。由于树突状细胞表达非常高水平的主要组织相容性复合体(MHC)II类产物,人们一直认为需要高水平的与MHC产物结合的配体(“信号一”)来刺激静止T细胞。在此,我们描述了细菌超抗原葡萄球菌肠毒素A(SEA)刺激人血T细胞的定量基础。超抗原用于信号一定量研究的优势在于这些配体:(a)结合MHC II类和T细胞受体,但不需要加工;(b)能有效地呈递给大量静止T细胞;(c)可在应用于T细胞之前脉冲加载到树突状细胞上。因此,可以将与树突状细胞相关的SEA量与随后的淋巴细胞刺激联系起来。使用放射性碘化SEA,我们注意到树突状细胞结合超抗原的能力比B细胞和单核细胞高30至200倍。然而,这种高SEA结合并不是树突状细胞向T细胞呈递抗原的强大效力的基础。在用SEA脉冲处理后,树突状细胞可以使使用针对合适CD45R表位的单克隆抗体分离出的静止T细胞致敏,此时SEA占据的表面MHC II类分子最多为0.1%。这相当于每个树突状细胞平均2000个分子。在这些低剂量的结合SEA情况下,针对CD3、CD4和CD28的单克隆抗体几乎完全阻断T细胞增殖。这些数据除了提示MHC II类在树突状细胞上的新作用,特别是在低外部浓度下捕获和保留配体的作用外,还揭示了只要这些低水平信号一在树突状细胞上传递,初始T细胞就能对其产生反应。